• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    104.27 Sep 2, 4:00PM EDT
    |Pre-Market : 104.93 Up 0.66 (0.63%) 9:00AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:104.27
    Open:N/A
    Bid:104.80 x 500
    Ask:105.00 x 400
    1y Target Est:126.83
    Beta:0.86019
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:N/A - N/A
    52wk Range:85.95 - 123.37
    Volume:1,145
    Avg Vol (3m):10,808,300
    Market Cap:153.03B
    P/E (ttm):11.00
    EPS (ttm):9.48
    Div & Yield:0.43 (1.64%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILD 0.00%153.03B
    PFE197.17B
    GSK98.23B

    Key Statistics

    Forward P/E (1 yr):8.96
    P/S (ttm):5.24
    Ex-Dividend Date:14-Sep-15

    Analysts

    Annual EPS Est (Dec-15) :11.69
    Quarterly EPS Est (Sep-15) :2.82
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback